HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | -72.4% | 211 | -73.9% | 0.00% | – |
| Q2 2023 | $29 | +383.3% | 807 | +366.5% | 0.00% | – |
| Q1 2023 | $6 | -97.7% | 173 | -96.2% | 0.00% | -100.0% |
| Q4 2022 | $262 | -95.6% | 4,591 | +3133.1% | 0.00% | – |
| Q3 2022 | $6,000 | -53.8% | 142 | -57.0% | 0.00% | – |
| Q4 2021 | $13,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | -13.3% | 330 | 0.0% | 0.00% | – |
| Q2 2021 | $15,000 | -53.1% | 330 | -56.6% | 0.00% | – |
| Q1 2021 | $32,000 | -15.8% | 760 | -15.6% | 0.00% | – |
| Q4 2020 | $38,000 | +11.8% | 900 | -30.8% | 0.00% | – |
| Q3 2020 | $34,000 | -37.0% | 1,300 | -35.0% | 0.00% | – |
| Q2 2020 | $54,000 | -85.6% | 2,000 | -89.6% | 0.00% | -100.0% |
| Q1 2018 | $376,000 | -3.1% | 19,172 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $388,000 | – | 19,172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |